What happened
A streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9
SourceSpringer Science and Business Media LLCpublicationBiotech
A streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9
Publication signal: A streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9
Factual summary
Why it matters
Recent source-backed research output for AISci Stage A browsing.
SourceSpringer Science and Business Media LLCLimitations
AISci rank score does not assess scientific quality or citation impact.
SourceSpringer Science and Business Media LLCLinked output
A streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9paperPeople
No reviewed person relationship is attached to this event.
Organizations
No reviewed organization relationship is attached to this event.
Topics
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
A streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9
A streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9
Genomics and Gene Editing
Controlled AISci Stage A topic for Genomics and Gene Editing.
Timeline
- publicationA streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9